Vir Biotechnology, Inc. VIR Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s change in other assets?
- Vir Biotechnology, Inc. (VIR) reported change in other assets of -$382K in Q1 2026.
- How has Vir Biotechnology, Inc.'s change in other assets changed year-over-year?
- Vir Biotechnology, Inc.'s change in other assets increased by 92.4% year-over-year, from -$5.06M to -$382K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.